Delivery Order SPE2DX22D0010-SPE2D825FHF91
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, valued at $17,035.67 with a firm fixed price structure. The award covers the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used primarily for attention-deficit/hyperactivity disorder treatment. The delivery order is non-competitive and represents a task order issued under AmerisourceBergen's existing Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Concerta ER (Extended Release) tablets 36 mg. This firm fixed-price delivery order, valued at approximately $42.9K, represents a non-competitive award under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The contract is scheduled for completion by August 1, 2025, with fulfillment occurring at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $6,995.49 firm fixed-price contract is for the delivery of Concerta ER 36 mg tablets, with a performance period through May 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $10,422.18 for the supply of 100 units of the prescription drug Concerta ER 36 mg tablets. The contract is a firm-fixed-price arrangement with the Defense Logistics Agency (DLA) and has an ultimate completion date of October 23, 2024. This award is not designated under any set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,773.86 firm fixed-price delivery order is for the supply of 4,566,597,685 Concerta ER 36 mg tablets. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,662.04 firm fixed-price delivery order is for the supply of 100 units of the medication Concerta ER 36 mg tablets. The award has an ultimate completion date of January 10, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHF91Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Concerta ER Tabs 36mg with a ceiling value of $21,856.30. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed pricing and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. The delivery order falls within AmerisourceBergen's established role as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's pharmaceutical distribution capabilities encompass a broad range of medications and medical supplies across multiple therapeutic domains. As a child contract issued under the larger IDC vehicle, this delivery order demonstrates the flexibility of the prime vendor model to fulfill specific medical supply requirements for the federal government's defense and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 7/29/25 |